NDC product
eribulin mesylate
NDC 60505-6435 · Apotex Corp.
Key facts
| Product NDC | 60505-6435 |
|---|---|
| Proprietary name | eribulin mesylate |
| Nonproprietary name | eribulin mesylate |
| Substances | ERIBULIN MESYLATE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Apotex Corp. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA218047 |
| Pharmacologic classes | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| Marketing start | Mar 19, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: